Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GigaGen
Biotech
GigaGen garners up to $135M BARDA bucks to beat botulism
The California-based biotech will work to clinically develop and manufacture antibodies that target seven botulinum toxin variants.
Darren Incorvaia
Oct 3, 2024 8:00am
Grifols ponies up $80M for polyclonal antibody biotech GigaGen
Mar 10, 2021 9:50am
GigaGen's COVID-19 drug candidate outruns plasma in lab tests
Aug 10, 2020 10:00am
GigaGen jumps into COVID-19 arena with polyclonal antibodies
Mar 30, 2020 7:05am
